Global Patient Blood Management Market was valued at USD 10.22 billion in 2019 which is expected to reach USD 16.88 billion by 2027 at a CAGR 7.8%.
Patient blood management is also called as (PBM) and it is standard plan for management of a patient’s blood to reduce the blood loss during surgery, optimize patient blood, and optimize tolerance of anemia. Patient blood management is a standard care plan which is performed by medical practitioners for patients.
Request Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Patient-Blood-Management-Market/request-sample
Increase in prevalence of targeted diseases is the driving factor which is expected to drive the global patient blood management market growth. Furthermore, rise in awareness regarding blood donation among people will have the positive impact on global patient blood management market growth. For instance, in 2017, according to National Health Commission (NHC) around 14.59 million people had donated blood across the world. Moreover, increase in demand for donated blood across the world which is expected to fuel the global patient blood management market growth. Also, increase in technological advancements is expected to propel the growth of patient blood management industry during this forecast period.
Get Discount on this report @ https://qualiketresearch.com/request-sample/Patient-Blood-Management-Market/ask-for-discount
Increase in demand for ambulatory infusion pumps in home care setting which is expected to drive the Global Patient Blood Management Market growth. Furthermore, rise in incidences of chronic diseases along with rapid growth of the geriatric population which is expected to propel the Global Patient Blood Management Market growth. Moreover, growing number of surgical procedures will have the positive impact on Global Patient Blood Management Market growth. Also, rise in approval activities by regulatory authority will fuel the growth of Global Patient Blood Management Market. For instance, May 2018, Baxter had received US FDA clearance for Spectrum IQ infusion system with Dose IQ safety software.
However, high cost of automated systems is the restraining factor which is expected to hamper the global patient blood management market.
Global Patient Blood Management Market is segmented into product such as Blood Transfusion Devices, Blood Processing Devices, Diagnostic and Testing Instruments, Blood Storage Devices, and Blood Culture Screening Devices, by component such as Plasma, and Whole Blood. Further, Global Patient Blood Management Market is segmented into end user such as Diagnostic Clinic & Pathology Labs, Hospitals, and Blood Banks.
Also, Global Patient Blood Management Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as
- Grifols, S.A.,
- Abbott Laboratories,
- Bio-Rad Laboratories, Inc.,
- Kaneka Corporation,
- Biomérieux SA,
- B. Braun Melsungen AG,
- Immucor, Inc.,
- Terumo Corporation,
- Fresenius Se & Co. KGaA, and
- Haemonetics Corporation.
Browse For Full Research Report @ https://qualiketresearch.com/reports-details/Patient-Blood-Management-Market
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.